Literature DB >> 10398609

Prescribing medicines for children.

A G Sutcliffe.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10398609      PMCID： PMC1116223          DOI： 10.1136/bmj.319.7202.70

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

1.  Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients--FDA. Final rule.

Authors: 
Journal:  Fed Regist       Date:  1998-12-02

2.  Fatal cardiovascular collapse of infants receiving large amounts of chloramphenicol.

Authors:  J M SUTHERLAND
Journal:  AMA J Dis Child       Date:  1959-06

3.  Circadian performance rhythms: some practical and theoretical implications.

Authors:  S Folkard
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1990-04-12       Impact factor: 6.237

4.  PRODIGY: implementing clinical guidance using computers.

Authors:  I N Purves
Journal:  Br J Gen Pract       Date:  1998-09       Impact factor: 5.386

5.  Prevention of medication errors in the pediatric inpatient setting. American Academy of Pediatrics. Committee on Drugs and Committee on Hospital Care.

Authors: 
Journal:  Pediatrics       Date:  1998-08       Impact factor: 7.124

6.  Unlicensed and off label drug use in paediatric wards: prospective study.

Authors:  S Turner; A Longworth; A J Nunn; I Choonara
Journal:  BMJ       Date:  1998-01-31

7.  Therapeutic orphans.

Authors:  H Shirkey
Journal:  J Pediatr       Date:  1968-01       Impact factor: 4.406

8.  Need for conducting research on medications unlabeled for use in pediatric patients.

Authors:  M C Nahata
Journal:  Ann Pharmacother       Date:  1994-09       Impact factor: 3.154

Review 9.  Noninvasive methods for drug measurement in pediatrics.

Authors:  B Bailey; J Klein; G Koren
Journal:  Pediatr Clin North Am       Date:  1997-02       Impact factor: 3.278

10.  Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports.

Authors:  T J Parke; J E Stevens; A S Rice; C L Greenaway; R J Bray; P J Smith; C S Waldmann; C Verghese
Journal:  BMJ       Date:  1992-09-12
View more
  7 in total

1.  Testing new pharmaceutical products in children.

Authors:  Alastair G Sutcliffe
Journal:  BMJ       Date:  2003-01-11

2.  Impact of an intervention to reduce prescribing errors in a pediatric intensive care unit.

Authors:  Amalia Martinez-Anton; J Ignacio Sanchez; Lidia Casanueva
Journal:  Intensive Care Med       Date:  2012-06-12       Impact factor: 17.440

Review 3.  Awareness, knowledge and views of off-label prescribing in children: a systematic review.

Authors:  S Balan; M A Hassali; V S L Mak
Journal:  Br J Clin Pharmacol       Date:  2015-11-06       Impact factor: 4.335

4.  Off label and unlicensed drug use among French office based paediatricians.

Authors:  M Chalumeau; J M Tréluyer; B Salanave; R Assathiany; G Chéron; N Crocheton; C Rougeron; M Mares; G Bréart; G Pons
Journal:  Arch Dis Child       Date:  2000-12       Impact factor: 3.791

5.  Effect of the pediatric exclusivity provision on children's access to medicines.

Authors:  Joanne Grieve; June Tordoff; David Reith; Pauline Norris
Journal:  Br J Clin Pharmacol       Date:  2005-06       Impact factor: 4.335

Review 6.  Maternal-fetal transport of hypoglycaemic drugs.

Authors:  Facundo Garcia-Bournissen; Denice S Feig; Gideon Koren
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

7.  Awareness and Views of Pharmacists and Physicians Toward Prescribing of Drugs for Off-Label Use in the Pediatric Population in Saudi Arabia.

Authors:  Dawood Alyami; Ajaim A Alyami; Abdulaziz Alhossan; Mohammed Salah
Journal:  Cureus       Date:  2022-03-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.